The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons - Wikidata - awgldk - TriplyDB

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

http://www.wikidata.org/entity/Q34380089

about

Molecular characterization of human and mouse fatty acid amide hydrolases Activity-dependent regulation of synapses by retrograde messengers The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin The endocannabinoid system as an emerging target of pharmacotherapy The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants Resolvins and aliamides: lipid autacoids in ophthalmology - what promise do they hold?Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory.Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death.Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture.Possible Anandamide and Palmitoylethanolamide involvement in human stroke.CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signaling Investigation of microcystin congener-dependent uptake into primary murine neurons.Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.Endocannabinoids in the dentate gyrus.Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures Pharmacological characterization of GPR55, a putative cannabinoid receptor Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.CB2: a cannabinoid receptor with an identity crisis The endocannabinoid system as a target for the treatment of neurodegenerative disease.How might cannabinoids influence sexual behavior?Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent manner The terms 'autacoid', 'hormone' and 'chalone' and how they have shifted with time.Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α Progesterone receptor and dopamine receptors are required in Delta 9-tetrahydrocannabinol modulation of sexual receptivity in female rats Regulation of neurite outgrowth by G(i/o) signaling pathways.Cannabinoid receptor CB2 modulates axon guidance Palmitoylethanolamide inhibits glutamate release in rat cerebrocortical nerve terminals Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Microglia produce and hydrolyze palmitoylethanolamide.Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.Cyclooxygenase-2 in synaptic signaling.

P2860

Q24317261-0091E9F9-4B55-412C-A556-7583AFB38B8B Q24614596-D427A4A3-E901-449D-8CA9-8ED6817115B9 Q24643876-368DFB3C-7421-4B5A-8CFE-7DD816A7E097 Q24648473-E53E2B0E-058A-49E4-809B-95379856A50A Q24651712-19F9AE2B-0EF6-47EB-A70C-AFDC49293D0B Q24685540-06113051-3B3E-415B-B993-6E4BCCC00945 Q28073034-F8C69133-D084-487A-8947-3178E3E70C27 Q28073952-C9A3DF54-2E7A-438D-8B6B-FE7EFA799371 Q28298445-B62338A4-FB5A-4503-B863-7B70D763F6D1 Q28363051-940741FB-7015-4E25-B3E7-476405996F5A Q28390536-9E7BD534-A773-4D03-BC08-30AC627F9709 Q30392902-C9E0110E-D9D8-4FEF-B57C-19E3EFFA2025 Q31019088-7930B213-AB16-4892-9425-D072BE7ACECB Q31807488-4F9B4D09-0B35-4F3C-8DBF-AE5D803363B6 Q32035079-6B67A188-170C-4B85-9E36-2234F3794357 Q33446413-2F00EFBE-B8A3-44A8-80F9-8FE909E35E7D Q33524983-43763435-F0D9-4CC2-A3ED-50E6E2E2F46D Q33578893-125ECCB2-E117-4645-9812-F18D132D1F6C Q33664105-29324DF3-5441-4CDF-910E-E25A5B5E628A Q33757950-8A872B28-356D-4E2C-A7B7-FABDA4CCDEA0 Q33794471-31168448-DFB0-4AD9-A941-08E6FF759DB4 Q33869340-E0D826AE-1D53-4368-A546-94085508CF05 Q33997873-B4330A2A-9F28-46C4-99AA-315BDDCAA955 Q34098185-AC14BB60-867A-4258-9951-9F1E71E65D08 Q34098196-01FDC7D5-3944-42D7-8D18-AA47210852D2 Q34131364-A4978986-BE3F-47D0-9217-D9609CCC955B Q34183654-0FF9FA7A-D93A-4754-9A89-A38A66A0009F Q34422088-E6FEBA42-4C12-4C6D-9EA9-29F028C1046A Q34520297-6DCC9B98-784A-410D-A475-A71AA0829EC3 Q34581274-B058690B-5262-4FEB-AEDE-E6832813D45C Q34636570-73FCAAC5-8F1E-4B7C-8289-F0415F856DFC Q34657854-6FE879AD-AA6F-4F94-996A-55F7B97EE1D1 Q34746354-33299F63-DF3E-4125-95A7-4B68B6B8FA71 Q34947873-FF12F7EE-C5DC-40E7-8063-22518F089657 Q35381177-EF067462-C940-491A-847F-883A7C253908 Q35499568-DF8C47A4-0E0F-446C-ABC8-A590424BDF42 Q36348374-83790B2B-6900-4B63-A74E-5D2FBB2AE991 Q36477987-3305DA16-CDDB-4C93-9583-A71DA38C98ED Q36653994-AE9C95D1-ECA0-4E90-B889-30F7E924E7A2 Q36922736-AFFED8C8-EE41-43FE-A40F-ACCEBEFC3EA1

P2860

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

http://www.wikidata.org/entity/Q34380089

description

1996 nî lūn-bûn

@nan

1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@ast

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@en

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@nl

type

label

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@ast

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@en

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@nl

prefLabel

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@ast

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@en

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@nl

P1433

Q34380089-4D3AAF07-9BB7-4EA8-A1B0-599BE894528C

P1476

Q34380089-5005DFD4-4081-491C-9E4C-9F30B0AD5656

P2093

Q34380089-134095AB-551C-499E-BD06-812FE2B78471

Q34380089-3EB262BB-D262-48F4-9DCD-85DDAD46FCA1

Q34380089-68F3AF2B-DB55-46D3-88FE-47A5E8093468

Q34380089-751651B6-96F6-482A-AE9F-0D37843FB1EB

Q34380089-A98AAA59-B3C6-48F7-A46F-E5338D257B37

Q34380089-B21A98C6-8C29-4D45-A517-5EB36EA634E4

Q34380089-CFA4E58E-C15B-472F-A5A4-A4A53A88C267

P2860

Q34380089-036D90F2-DBE5-405C-A988-F4F67A5FCC65

Q34380089-0BFF7B3D-368E-4998-84AC-733623D6446D

Q34380089-12BCF303-6782-4296-9C9B-5E7CB13AF311

Q34380089-13509E15-F252-4278-A74A-DAC64C93AB1A

Q34380089-140FC60B-96C4-40BB-8747-2B50033CA0F1

Q34380089-17CAFC3C-9A96-44CE-878D-9F417C17162E

Q34380089-2081154E-2838-4C3F-9BEB-49ECEFEC976C

Q34380089-25D30B9F-B809-4CDD-B8C3-A3A255F80F07

Q34380089-29741448-5B01-4CD7-BBB3-E0836698FB0A

Q34380089-298AC4B4-15A3-42CC-8BCF-9CBBFC6D0782

P304

Q34380089-9FF029A4-E25C-4A32-B13A-715EA17DDFE6

P31

Q34380089-15159427-92EA-47F2-9659-D547CB312B3F

P356

Q34380089-88119175-1985-40DC-9000-C3B0CD9C74C8

P407

Q34380089-DC039718-799A-4664-BB8C-E91AFEE48A45

P433

Q34380089-C27CAB72-70E5-4A5A-A1AB-9825BE25C487

P478

Q34380089-FE74F6EC-AAAA-4212-BCE5-761F61CBFA07

P577

Q34380089-FC0A1B61-0D65-46B3-8634-683AC7428DF8

P5875

Q34380089-BCBD0EA6-97F2-476F-BC33-42ED568E73AA

P698

Q34380089-7997D06E-919E-43A8-A1C9-4D6A6EC9A526

P921

Q34380089-72A7A489-B8CD-4079-A924-08D932EF0B92

Q34380089-CA2CB15D-0F1F-4FED-85CE-60126BD46CC4

P932

Q34380089-84F5FBB1-CBC5-44E9-8017-71E3CB500D32

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

The ALIAmide palmitoylethanola ...... in cerebellar granule neurons

@en

P2093

A Buriani

http://www.w3.org/2001/XMLSchema#string

A Leon

http://www.w3.org/2001/XMLSchema#string

L Facci

http://www.w3.org/2001/XMLSchema#string

L Petrelli

http://www.w3.org/2001/XMLSchema#string

R Dal Toso

http://www.w3.org/2001/XMLSchema#string

S D Skaper

http://www.w3.org/2001/XMLSchema#string

S Romanello

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

Molecular characterization of a peripheral receptor for cannabinoids

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

Determination and characterization of a cannabinoid receptor in rat brain

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

P304

3984-3989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.93.9.3984

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1996-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14567563

http://www.w3.org/2001/XMLSchema#string

P698

8633002

http://www.w3.org/2001/XMLSchema#string

P921

P932

39472

http://www.w3.org/2001/XMLSchema#string